BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Meyer HJ, Wienke A, Surov A. Associations between GLUT expression and SUV values derived from FDG-PET in different tumors-A systematic review and meta analysis. PLoS One 2019;14:e0217781. [PMID: 31206524 DOI: 10.1371/journal.pone.0217781] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Wang C, Xu R, Song J, Chen Y, Yin X, Ruze R, Xu Q. Prognostic value of glycolysis markers in pancreatic cancer: A systematic review and meta-analysis. Front Oncol 2022;12:1004850. [DOI: 10.3389/fonc.2022.1004850] [Reference Citation Analysis]
2 Menon N, Mandelkern M. Utility of PET Scans in the Diagnosis and Management of Gastrointestinal Tumors. Dig Dis Sci 2022. [PMID: 35908126 DOI: 10.1007/s10620-022-07616-3] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Takahashi M, Yoshimura S, Takyu S, Aikou S, Okumura Y, Yagi K, Fukayama M, Momose T, Seto Y, Yamaya T. A design of forceps-type coincidence radiation detector for intraoperative LN diagnosis: clinical impact estimated from LNs data of 20 esophageal cancer patients. Ann Nucl Med 2021. [PMID: 34843102 DOI: 10.1007/s12149-021-01701-9] [Reference Citation Analysis]
4 Cazzato G, Colagrande A, Cimmino A, Abbatepaolo C, Bellitti E, Romita P, Lospalluti L, Foti C, Arezzo F, Loizzi V, Lettini T, Sablone S, Resta L, Cormio G, Ingravallo G, Rossi R. GLUT1, GLUT3 Expression and 18FDG-PET/CT in Human Malignant Melanoma: What Relationship Exists? New Insights and Perspectives. Cells 2021;10:3090. [PMID: 34831313 DOI: 10.3390/cells10113090] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Minamimoto R, Endo H. Cell Proliferation PET Imaging with 4DST PET/CT in Colorectal Adenocarcinoma and Adenoma. Diagnostics (Basel) 2021;11:1658. [PMID: 34573999 DOI: 10.3390/diagnostics11091658] [Reference Citation Analysis]
6 Reyes Marlés RH, Navarro Fernández JL, Puertas García-Sandoval JP, Santonja Medina F, Mohamed Salem L, Frutos Esteban L, Contreras Gutiérrez JF, Castellón Sánchez MI, Ruiz Merino G, Claver Valderas MA. Clinical value of baseline 18F-FDG PET/CT in soft tissue sarcomas. Eur J Hybrid Imaging 2021;5:16. [PMID: 34476632 DOI: 10.1186/s41824-021-00110-5] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Pliszka M, Szablewski L. Glucose Transporters as a Target for Anticancer Therapy. Cancers (Basel) 2021;13:4184. [PMID: 34439338 DOI: 10.3390/cancers13164184] [Cited by in Crossref: 1] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhang M, Yang J, Jiang H, Jiang H, Wang Z. Correlation between glucose metabolism parameters derived from FDG and tumor TNM stages and metastasis-associated proteins in colorectal carcinoma patients. BMC Cancer 2021;21:258. [PMID: 33750337 DOI: 10.1186/s12885-021-07944-z] [Reference Citation Analysis]
9 Ha LN, Iravani A, Nhung NT, Hanh NTM, Hutomo F, Son MH. Relationship between clinicopathologic factors and FDG avidity in radioiodine-negative recurrent or metastatic differentiated thyroid carcinoma. Cancer Imaging 2021;21:8. [PMID: 33413689 DOI: 10.1186/s40644-020-00378-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
10 Yoshimura S, Takahashi M, Aikou S, Okumura Y, Jinbo K, Onoyama H, Urabe M, Kawasaki K, Yagi K, Nishida M, Mori K, Yamashita H, Nomura S, Koyama K, Momose T, Abe H, Ushiku T, Fukayama M, Seto Y. One-by-One Comparison of Lymph Nodes Between 18F-FDG Uptake and Pathological Diagnosis in Esophageal Cancer. Clin Nucl Med 2020;45:741-6. [PMID: 32796247 DOI: 10.1097/RLU.0000000000003224] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
11 Pezzuto A, D'Ascanio M, Ricci A, Pagliuca A, Carico E. Expression and role of p16 and GLUT1 in malignant diseases and lung cancer: A review. Thorac Cancer 2020;11:3060-70. [PMID: 32945604 DOI: 10.1111/1759-7714.13651] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
12 Cheng NM, Hsieh CE, Fang YD, Liao CT, Ng SH, Wang HM, Chou WC, Lin CY, Yen TC. Development and validation of a prognostic model incorporating [18F]FDG PET/CT radiomics for patients with minor salivary gland carcinoma. EJNMMI Res 2020;10:74. [PMID: 32632638 DOI: 10.1186/s13550-020-00631-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Moradi F, Iagaru A. The Role of Positron Emission Tomography in Pancreatic Cancer and Gallbladder Cancer.Semin Nucl Med. 2020;50:434-446. [PMID: 32768007 DOI: 10.1053/j.semnuclmed.2020.04.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
14 Ono K, Takigawa S, Yamada K. L-Glucose: Another Path to Cancer Cells. Cancers (Basel) 2020;12:E850. [PMID: 32244695 DOI: 10.3390/cancers12040850] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Lee HL, Farrell R, Kamath V, Ho-Shon I, Yap F. Concordant PET/CT and ICG positive lymph nodes in endometrial cancer: a case of mistaken identity. J Surg Case Rep 2020;2020:rjz377. [PMID: 31976060 DOI: 10.1093/jscr/rjz377] [Reference Citation Analysis]
16 Suh HY, Choi H, Paeng JC, Cheon GJ, Chung JK, Kang KW. Comprehensive gene expression analysis for exploring the association between glucose metabolism and differentiation of thyroid cancer. BMC Cancer 2019;19:1260. [PMID: 31888560 DOI: 10.1186/s12885-019-6482-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]